Company: BLNE
Filing Date: 2025-03-27
Form Type: 424B7
Source: 0001641172-25-000822
Chunk: 18

Company: Beeline Holdings, Inc.
Filing Date: 2025-03-27
Form: 424B7
Chunk 18
---
 as applicable, of common stock are subject to certain agreed upon                
 maximum amount limitations set forth in the Purchase Agreement. Also, the Purchase Agreement               
 prohibits us from issuing and selling any shares of our common stock to C/M to the extent                  
 such shares, when aggregated with all other shares of our common stock then beneficially                   
 owned by C/M, would cause C/M’s beneficial ownership of our common stock to exceed                         
 the 4.99% beneficial ownership limitation.                                                                 |

| S-20 |

| (2) | Applicable                                                                        
 percentage ownership is based on 7,211,944 shares of our common stock outstanding 
 as of March 25, 2025. Does not include additional shares of common stock, which   
 we expect our Chief Executive Officer to receive when he converts his Series G.   |

| (3) | Assumes                                                                                         
 the sale of all 1,666,667 shares being offered pursuant to this prospectus supplement,          
 estimated at an assumed offering price of $2.10 per share. Does not include sales               
 which may be made under prior prospectus supplements or otherwise pursuant to the Purchase      
 Agreement other than the $3,500,000 of sales being registered under this prospectus supplement. |

| (4) | The                                                                           
 business address of C/M is 1111 Brickell Avenue, Suite 2920, Miami, FL 33131. |

| (5) | Assumes                                                                                         
 sales at an average price of $2.10. The number of shares we sell may be more or less            
 since the price per share will be based upon future markets prices. Does not include sales      
 which may be made under prior prospectus supplements or otherwise pursuant to the Purchase      
 Agreement other than the $3,500,000 of sales being registered under this prospectus supplement. |

<div align='center'>CAPITALIZATION</div>

Following shareholder approval of conversions of our Series F, Series F-1, and Series G, and certain other securities, and conversions of certain shares of such convertible preferred stock which occurred on March 7, 2025, assuming no further capital raising (other than the up to $3,500,000 in sales under the ELOC to which this prospectus supplement relates), our common stock and preferred stock and derivative securities outstanding, on a fully-diluted basis, after giving effect to the sale of common stock hereunder at an assumed offering price of $2.10 per share, consist of the following:

| Class, Series or Type